More than 70 international speakers and over 1000 delegates are set to convene on London next month for policy debates,...
The team at Prohibition Partners shares how they think things will shape up for medical cannabis in 2026.
In the first of a series of deep dives in the UK market, we look into its rapid growth, the shift in dominance of popular strains,...
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
Healthcare professionals attending the Cannabis Health Symposium next month will be able to earn CPD points to support their professional development. The Cannabis Health Symposium is...
New guidelines aim to bring more clarity and consistency to the practice of prescribing cannabis-based medicines in the UK.
Jordan Stephens aims to shed light on the role of alternative treatments in supporting mental wellbeing.
The Medical Cannabis Clinicians Society (MCCS) and Curaleaf Laboratories have formed a new partnership aimed at addressing critical knowledge gaps.
The UK’s long-running project to regulate CBD (cannabidiol) products has taken another major step forward, seeing thousands of products make it to the final phase of...
Findings from The European Cannabis Report: 10th Edition reflect a decade of immense change across European cannabis markets.
